Venova Medical, Inc.

Thank you Robert Shahverdyan, MD for your continued contributions to percutaneous AV Fistula creation! #endoAVF #pAVF #Velocity #LINC2025 #vascularaccess

Congratulations to PI Rishi Razdan, M.D. and his colleagues at Azura Vascular Care in Jacksonville, FL for enrolling their first subjects in the VENOS-2 Early Feasibility Study of the Velocity pAVF System. We are tremendously grateful for their support and dedication to this study! #pAVF #venovamedical #AVFistula #velocitypAVF #dialysis #endoAVF #venos-2

We are excited to announce the initiation and enrollment of the first subjects in the VENOS-2 early feasibility study of our Velocity pAVF System. A tremendous thank you to Dr. Rashid Sharaf and colleagues at Star Vascular and the Clinical Advancement Center for their tremendous efforts to make this possible. #pAVF #venovamedical #AVFistula #velocitypAVF #dialysis #endoAVF #venos-2 https://lnkd.in/eaHjPNxi

We're #hiring a new Manager, Clinical Affairs in Los Gatos, California. Apply today or share this post with your network.

With one-year trial outcomes, technique recommendations, and meeting updates, October brought with it some important updates! Don't miss out on any of them and check out the Renal Interventions' Top 10 stories from October 2024, featuring news from Venova Medical, Inc., Akebia Therapeutics, B. Braun Medical Inc. (US), and BD! Follow the link below to read the full list and view all articles

Venova Medical to Present Results from VENOS-1 Study at American Society of Nephrology (ASN) Kidney Week 2024 An oral abstract reporting results from the VENOS-1 study (NCT 05757726) using Venova Medical’s VelocityTM pAVF System will be presented during the upcoming ASN meeting in San Diego. Here are the details: Presentation Title: Midterm Outcomes of a Novel First-in-Human Percutaneous Arteriovenous Fistula Session Name: Dialysis Vascular Access: Research Advances Session Date: Saturday, October 26, 2024 Presentation Time: 05:40 PM – 05:50 PM Location: Room 8, San Diego Convention Center Presenter: Dirk Hentschel, MD, Brigham and Women’s Hospital, Boston, Massachusetts, United States View the abstract at https://lnkd.in/d_2drEid hashtag #pAVF #venovamedical #AVFistula #dialysis #dirkhentschel

This morning, at the Controversies in Dialysis Access (CiDA) 2024 meeting (3–5 October, Washington D.C., USA), Robert Shahverdyan, MD 🇦🇲🇩🇪 (Hamburg, Germany) gave a presentation sharing the one-year results of the VENOS-1 first-in-human study, which examined the Velocity (Venova Medical, Inc.) percutaneous arteriovenous fistula (pAVF). To learn more about these new results, follow the link below to read the full article!

Some additional coverage of our latest press release. #venova #velocitysystem #pavf

We are pleased to announce the closing of a $30M Series B financing co-led by Catalyst Health Ventures and a leading medical device company. We are also thrilled to announce that Darshana Zaveri will join our board of directors. We are appreciative for the incredible support from the new and existing investors who participated in the financing. This financing will support our upcoming clinical studies and our mission to transform and simplify how those who suffer from CKD and ESRD receive vascular access for hemodialysis. #pAVF #venovamedical #AVFistula #catalysthealthventures #dialysis #endoAVF https://lnkd.in/gxvkeHEU

Thank you Dr. Shahverdyan, Dr. Bala, Dr. Sharaf and Dr. Dolmatch for spending a day in the lab with the Velocity System!